Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,599.00
Bid: 1,594.50
Ask: 1,595.50
Change: -19.00 (-1.17%)
Spread: 1.00 (0.063%)
Open: 1,608.00
High: 1,615.00
Low: 1,575.00
Prev. Close: 1,618.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET COMMENT: US Stocks To Open Cautiously Higher, Earnings In Focus

Wed, 23rd Jul 2014 11:49

LONDON (Alliance News) - US stocks are set to open cautiously higher Wednesday, boosted by the the lack of consensus among EU leaders to impose sector-wide sanctions on the Russian economy, but muted in trepidation of a raft of corporate earnings.

Currently, the DJIA, the S&P 500, and the Nasdaq Composite all look set to open about 0.1% higher.

Investors have had a mixed reaction to the big technology stock earnings released after the market close Tuesday. Apple shares are 0.5% lower in the pre-market despite beating earnings per share expectations as sales were slightly lighter than expected, while Microsoft shares are about 1.5% higher after it announced its own numbers.

The focus will remain on US earnings, particularly the biotechnology and social media stocks given Fed Chair Janet Yellen's recent comments that valuations in those particular sectors look "stretched." All eyes will be on Facebook the company reports after the US closing bell.

"While the Federal Reserve is perhaps not the best source of equity analysis the comments do highlight the importance of today’s earnings reports from Biogen, Gilead Sciences and Facebook in justifying overall stock market valuations," said CMC Markets market analyst Jasper Lawler.

Pepsico has done what its soft drink rival Coca-Cola failed to do on Tuesday and impressed the market with its second quarter results, announcing earnings per share of USD1.32, ahead of the consensus expectation of USD1.23. Pepsico shares are moving higher in the premarket.

Amid a heightened focus on the airline after it decided to cancel all flights to Tel-Aviv on Tuesday due to a rocket exploding near the airport, Delta Airlines has reported second quarter earnings per share of USD0.94, up from USD0.8 a year earlier.

The US followed Delta's decision with a short-term ban on all flights to Tel-Aviv's Ben Gurion airport, although that didn't stop Secretary of State John Kerry landing there earlier Wednesday to attempt to advance ceasefire talks as the death toll from the conflict nears 650. The longer a flight ban to Tel-Aviv lasts, the greater the pressure on the US to broker a solution, both from the perspective of the economic effect on Israel, and frustrated US-Israelis and influential American Jews. Former New York Mayor Michael Bloombeg issued a statement Wednesday saying, "the flight restrictions are a mistake that hand Hamas an undeserved victory and should be lifted immediately."

US MBS mortgage applications jumped 2.4% in the week ended July 18, after falling 3.6% in the previous week. The only other release of note in the data calendar Wednesday is the eurozone consumer confidence index at 1500 BST, which is expected to remain unchanged in July at negative 7.5.

Ahead of the US opening bell, UK stocks are continuing to trade modestly higher, with the FTSE 100 up 0.2% at 6,806.01, the FTSE 250 up 0.3% at 15,697.82, and the AIM All-share up 0.1% at 773.07.

GlaxoSmithKline has dropped to the bottom of the FTSE 100, down 2.9%, after reporting a drop in first-half pretax profit to GBP1.89 billion from GBP2.70 billion in the previous year. Group revenue was also down to GBP11.17 billion from GBP13.1 billion. Glaxo said that full-year core earnings per share is now expected to be broadly similar to 2013.

Bank of England Governor Mark Carney has been speaking at a business conference in Glasgow ahead of the opening of the Commonwealth Games there, and following the release of the the latest BoE meeting minutes earlier Wednesday. After beginning with a games pun about the UK economy being the current holder of "fastest growing advanced economy in the world title," Carney went on to put the quarterly inflation report, due next month, squarely in focus for central bank watchers.

The BoE chief reiterated his recent message that real wage growth is now the key indicator as to when rates will rise, and that currently there are conflicting messages in the labour market, namely that unemployment is rapidly falling, but wage growth is stagnant.

"A key judgement for the MPC is when and to what extent these developments will translate into real wage growth, and in turn that wage growth into price pressures," Carney said. "Next month's Inflation Report provides the next opportunity to update our thinking on these important questions."

Carney also reiterated that the main risk to the UK economic recovery is an overheating of the housing market and the prospect of UK households indebtedness, which he used as one of the explanations for future rate rises being gradual.


By Jon Darby; jondarby@alliancenews.com; @jondarby100

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
3 Jun 2024 17:20

European shares kick-off June on a high note in anticipation of ECB rate cut

GSK tumbles as Zantac lawsuits allowed to proceed

*

Read more
3 Jun 2024 17:19

Pharma, energy stocks drag London's FTSE 100; ECB rate cut hopes cap losses

FTSE 100 down 0.2%, FTSE 250 up 0.8%

*

Read more
3 Jun 2024 17:00

LONDON MARKET CLOSE: FTSE 100 down amid shaky start in New York

(Alliance News) - The FTSE 100 in London closed lower on Monday, marking a mixed start to June, with GSK firmly at the bottom of the index.

Read more
3 Jun 2024 14:01

GSK immunotherapy bowel cancer drug works for 100% of patients

(Alliance News) - An immunotherapy drug could spare bowel cancer patients the need for surgery and chemotherapy after results showed it was effective in 100% of cases.

Read more
3 Jun 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 up, while Labour commits to defence

(Alliance News) - Stock prices in London were up at midday, after data from S&P Global signalled a return to growth for the UK manufacturing sector.

Read more
3 Jun 2024 09:08

TOP NEWS: GSK vows to appeal adverse Delaware court ruling on Zantac

(Alliance News) - GSK PLC on Monday said it will appeal a US court ruling that it should face jury trials relating to cases concerning the heartburn drug, Zantac.

Read more
3 Jun 2024 08:37

LONDON MARKET OPEN: Stocks up amid slew of manufacturing PMIs

(Alliance News) - Stock prices in London opened higher on Monday, ahead of local purchasing managers index data, and comparative prints from several other major global economies.

Read more
3 Jun 2024 08:00

LONDON BRIEFING: FTSE 100 seen up; GSK defends ranitidine cancer claim

(Alliance News) - Stocks in London are set to open higher on Monday, ahead of a data-heavy week, kicked off by a slew of manufacturing purchasing managers' index readings.

Read more
3 Jun 2024 07:30

GSK to appeal Delaware ruling on jury trials in Zantac cancer cases

(Sharecast News) - GSK shares were down almost 10% on Monday after a US court ruled that jury trials could hear expert witnesses in 70,000 cases brought by cancer sufferers claiming its Zantac heartburn drug caused their condition.

Read more
1 Jun 2024 21:35

Delaware judge lets more than 70,000 Zantac lawsuits go forward

June 1 (Reuters) - A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer.

Read more
1 Jun 2024 21:07

Delaware judge lets more than 70,000 Zantac lawsuits go forward

June 1 (Reuters) - A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer.

Read more
31 May 2024 17:45

US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label

May 31 (Reuters) - The U.S. Food and Drug Administration approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product.

Read more
31 May 2024 16:01

US FDA approves Moderna's RSV vaccine, its second marketed product

May 31 (Reuters) - The U.S. Food and Drug Administration has approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product.

Read more
30 May 2024 20:56

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 30 (Reuters) - A third U.S. dairy worker tested positive for bird flu after exposure to infected cows, and was the first to suffer respiratory symptoms, U.S. officials said on Thursday in the latest expansion of the outbreak. Bird flu has been found in dairy cattle in nine states. This second case in a Michigan dairy worker was found through increased testing of people and cows in the state following the April 1 identification of a case in a Texas farm worker. Here's what you need to know about the outbreak.

WHY IS H5N1 OR BIRD FLU A CONCERN?

Read more
30 May 2024 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.